[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR042543A1 - Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides - Google Patents

Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides

Info

Publication number
AR042543A1
AR042543A1 ARP030104723A ARP030104723A AR042543A1 AR 042543 A1 AR042543 A1 AR 042543A1 AR P030104723 A ARP030104723 A AR P030104723A AR P030104723 A ARP030104723 A AR P030104723A AR 042543 A1 AR042543 A1 AR 042543A1
Authority
AR
Argentina
Prior art keywords
decongestant
histamine
nsaid
descongestives
histaminic
Prior art date
Application number
ARP030104723A
Other languages
English (en)
Inventor
Roger Glen Berlin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR042543(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR042543A1 publication Critical patent/AR042543A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica y método para el tratamiento de la rinitis y síntomas similares al resfrío, el cual incluye la droga anti-inflamatoria no-esteroidal (NSAID), un descongestivo, y un anti-histamínico. La composición puede contener ibuprofeno, clorfenilamina y seudoefedrina, entre otros. Se ha descubierto que una NSAID aumenta la actividad de un descongestivo y un anti-histamínico, permitiendo así una reducción en cada uno o ambos en la administración de formas de dosis separadas. El mismo aumento también puede ocurrir con un anti-tusivo. Entonces, la cantidad efectiva del descongestivo o del anti-histamínico o ambos es menor a aproximadamente el 75% de una cantidad presente en una dosis aprobada del descongestivo o el anti-histamínico, o ambos, relativa a una cantidad de NSAID correspondiente a aproximadamente el 100% de una cantidad presente en una forma de dosis de fuerza normal de la NSAID.
ARP030104723A 2002-12-18 2003-12-18 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides AR042543A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43434202P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
AR042543A1 true AR042543A1 (es) 2005-06-22

Family

ID=32682029

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104723A AR042543A1 (es) 2002-12-18 2003-12-18 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides

Country Status (19)

Country Link
US (1) US7863287B2 (es)
EP (1) EP1572206B1 (es)
JP (1) JP2006515299A (es)
CN (2) CN1726035A (es)
AR (1) AR042543A1 (es)
AU (1) AU2003301188B2 (es)
CA (1) CA2508611C (es)
CL (1) CL2003002653A1 (es)
CO (1) CO5640087A2 (es)
ES (1) ES2468217T3 (es)
HK (2) HK1078494A1 (es)
MX (1) MXPA05006331A (es)
NZ (1) NZ540289A (es)
PE (2) PE20040973A1 (es)
PT (1) PT1572206E (es)
RU (1) RU2322262C2 (es)
TW (1) TWI313598B (es)
WO (1) WO2004056320A2 (es)
ZA (1) ZA200504908B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
US20100143471A1 (en) * 2007-03-21 2010-06-10 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
US8252330B2 (en) 2009-01-05 2012-08-28 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8377475B2 (en) 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
ES2527568T3 (es) * 2009-10-26 2015-01-26 Sephoris Pharmaceuticals, Llc Tratamiento de quemaduras solares usando analgésicos y antihistamínicos
JP5777906B2 (ja) * 2010-02-26 2015-09-09 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
AU2011250485B2 (en) * 2010-05-03 2016-07-07 Tsh Biopharm Corporation, Limited Pharmaceutical composition and method for treating hypertension
KR20180009813A (ko) * 2010-07-19 2018-01-29 프로갑스 에스.에이. 캡슐 내부에 캡슐 또는 다른 고형 제형을 캡슐화하는 것을 위한 장치 및 방법
JP5898964B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
JP5898963B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
US9216181B2 (en) * 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
CN105188760A (zh) * 2013-03-12 2015-12-23 赫尔克里士公司 共处理的涂覆有硅石的聚合物组合物
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
NZ735777A (en) * 2015-03-26 2023-03-31 Jacqueline M Iversen Methods and compositions to inhibit symptoms associated with veisalgia
CN104758935B (zh) * 2015-04-10 2017-11-21 海口世康药物研究有限公司 一种改善复方布洛芬制剂稳定性的组合物及其制备方法
WO2018058009A1 (en) 2016-09-26 2018-03-29 The Procter & Gamble Company Extended relief dosage form

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4906625A (en) 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4755532A (en) 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4585783A (en) 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4683243A (en) 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4522826A (en) 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
AU738274B2 (en) 1984-04-09 2001-09-13 Procter & Gamble Company, The Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4871733A (en) 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4840962A (en) 1984-04-09 1989-06-20 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4829064A (en) 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
US5288479A (en) 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
WO1992004021A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Method for providing improved analgesic effect
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
US5196436A (en) 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
CA2107331A1 (en) 1991-04-01 1992-10-02 Robert T. Sims Ibuprofen-decongestant combinations
US5492689A (en) 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2084028A1 (en) 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6303632B1 (en) 1992-09-03 2001-10-16 Sepracor Inc. Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
JPH08506808A (ja) * 1992-12-21 1996-07-23 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
EP0674517A1 (en) 1992-12-21 1995-10-04 The Procter & Gamble Company Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
ES2179075T3 (es) 1993-06-04 2003-01-16 Warner Lambert Co Preparaciones que contienen dioxido de silicio para mejorar su sabor.
US5466865A (en) 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
AU7604194A (en) 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
KR100338877B1 (ko) * 1993-10-25 2002-12-05 메렐 파마슈티칼스 인크. 테르페나딘과이부프로펜의안정한약제학적조성물
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5622723A (en) 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
JPH11510168A (ja) * 1995-07-28 1999-09-07 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5895663A (en) 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5869479A (en) 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
CN1278728A (zh) 1997-09-19 2001-01-03 普罗克特和甘保尔公司 治疗呼吸系统疾病的组合物和方法
US6337091B1 (en) 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
EP1032392A4 (en) 1997-10-29 2001-05-09 J Med Pharmaceuticals Inc RHINITIS TREATMENT BY ANTIHISTAMINE / DECONGESTIVUM ADMINISTRATION
US6090411A (en) 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
WO2001045676A2 (en) 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
WO2003024427A1 (en) 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
JP2002316927A (ja) 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd 感冒用組成物
WO2002096406A1 (fr) 2001-05-25 2002-12-05 Ssp Co., Ltd. Compositions medicinales
WO2003089007A1 (en) 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
AU2003302447A1 (en) 2002-11-22 2004-06-18 Kumamoto Technology And Industry Foundation Moving body navigate information display method and moving body navigate information display device
WO2005063219A2 (en) 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules

Also Published As

Publication number Publication date
JP2006515299A (ja) 2006-05-25
EP1572206A4 (en) 2007-07-18
TW200413004A (en) 2004-08-01
AU2003301188A1 (en) 2004-07-14
US7863287B2 (en) 2011-01-04
NZ540289A (en) 2006-10-27
EP1572206B1 (en) 2014-04-23
CO5640087A2 (es) 2006-05-31
RU2322262C2 (ru) 2008-04-20
CA2508611A1 (en) 2004-07-08
CL2003002653A1 (es) 2005-04-22
US20040186184A1 (en) 2004-09-23
MXPA05006331A (es) 2005-08-26
TWI313598B (en) 2009-08-21
WO2004056320A2 (en) 2004-07-08
CN102406642A (zh) 2012-04-11
PE20081072A1 (es) 2008-08-15
CN102406642B (zh) 2013-04-03
WO2004056320A3 (en) 2004-09-23
AU2003301188B2 (en) 2009-07-02
PE20040973A1 (es) 2004-12-14
EP1572206A2 (en) 2005-09-14
HK1078494A1 (en) 2006-03-17
ZA200504908B (en) 2006-12-27
RU2005122403A (ru) 2006-01-20
HK1166602A1 (en) 2012-11-02
CN1726035A (zh) 2006-01-25
ES2468217T3 (es) 2014-06-16
CA2508611C (en) 2011-07-26
PT1572206E (pt) 2014-06-12

Similar Documents

Publication Publication Date Title
AR042543A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides
CR9842A (es) Composiciones de celecoxib
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
UY30537A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
PE20040134A1 (es) Forma de dosificacion de una vez al dia de pramipexol
AR005281A1 (es) Composicion farceutica oral , procedimientos para su manufactura y uso de esa composicion farmaceutica para la preparacion de medicamentos. .
TW200609004A (en) Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihistamines
NO20051934L (no) Sfingosin-1-fosfatreseptoragonister ved behandling av demyelinerende lidelser.
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
NO20073403L (no) Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1
AR062659A1 (es) Composicion de liberacion sostenida de levodopa y metodo para su uso
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
UY28517A1 (es) Nueva combinación
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
UY26422A1 (es) Método para administrar un inhibidor de fosfodiesterasa 4
AR065139A1 (es) Medicamento para el tratamiento de la endometriosis
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
CO5640069A2 (es) Forma de dosificacion oral de mesilato de saquinavir
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
ES2526359T3 (es) Formulación galénica oral que comprende ketorolaco y vitaminas del complejo B, en la que la vitamina B6 se encuentra en una capa externa separada del resto de principios activos
AR043370A1 (es) Composiciones farmaceuticas de administracion oral y metodos para evitar la interaccion alimento -droga
CO5700723A2 (es) Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca
AR048958A1 (es) Medicamento en forma de pelicula para administracion por via oral, que contiene estriol

Legal Events

Date Code Title Description
FB Suspension of granting procedure